Davis Polk advised the representatives of the several purchasers in offering.Ionis Pharmaceuticals, Inc. executed its offering of an aggregate principal amount of $632.5 million of its 0%…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
